5 Things You Need To Know About Bayesian Response-Adaptive Design

During phase 2 studies, it can be a challenging and lengthy process to assess dose-effect signals when multiple doses and a placebo are involved. Alternative study designs, like the Bayesian response-adaptive design, are becoming increasingly popular in phase 2 studies where the goal is to identify the optimal dose(s) for phase 3 studies to confirm efficacy.

For sponsors considering a Bayesian response-adaptive design, this guide provides the five things you need to know prior to developing your protocol.